CAS: 220651-94-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ruplizumab REF: TM-T76825CAS: 220651-94-5 | 95% - 95% | 230.00 €~1,644.00 € | Tue 01 Apr 25 |
 | Ruplizumab REF: 3D-CLA1059CAS: 220651-94-5 | - - - | 1,191.00 €~2,874.00 € | Mon 12 May 25 |
Ruplizumab
CAS:220651-94-5
PF-03732010 is a humanized antibody targeting P-calmodulin with antitumor and antimetastatic activity.
Purity:
95% - 95%
Color and Shape:
Liquid
Ref: TM-T76825
| 1mg | 230.00 € | ||
| 5mg | 602.00 € | ||
| 10mg | 822.00 € | ||
| 25mg | 1,216.00 € | ||
| 50mg | 1,644.00 € |
Estimated delivery in United States, on Tuesday 1 Apr 2025
Ruplizumab
CAS:220651-94-5
Humanized whole monoclonal antibody targeting CD154; designed to treat rheumatic diseases
Ref: 3D-CLA1059
| 1mg | 1,191.00 € | ||
| 5mg | 2,083.00 € | ||
| 10mg | 2,874.00 € |
Estimated delivery in United States, on Monday 12 May 2025
